Transarterial chemoembolization for neuroendocrine tumor liver metastases: A 15-years monocentric experience

#3169

Introduction: Sequential Transarterial Chemoembolization (TACE) may be considered repetitively during the course of the disease. However, evaluation methods remain controversial.

Aim(s): To evaluate the efficacy of TACE on neuroendocrin tumor (NET) liver metastases, and the correlation between response on imaging and survival

Materials and methods: This single center retrospective analysis included all patients with NET liver metastases treated with TACE, from January 2003 to December 2017. Tumor response (RECIST and mRECIST), time to liver progression (TTLP), time to untreatable progression with TACE (TTUP), and overall survival (OS) were analysed. Patient, tumor and treatment characteristics were evaluated as prognostic factors

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author:

Authors: Touloupas C, Faron M, Deschamps F, Hadoux J, Roux C,

Keywords: neuroendocrine, liver metastases, chemoembolization, intra-arterial therapies, mRECIST,